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Introduction
Recent advances in macrophage biology have revealed several 
subpopulations. One prominent categorization separates Ly6C+ 
monocyte-derived macrophages into M1 (destructive, inflam-
matory) and M2 (healing, immunoregulatory) subsets. Mono-
cytes differentiate into an immunoregulatory M2 phenotype 
in response to IL-13 and IL-4 (1, 2) and are characterized by ex-
pression of the arginine-catabolizing enzyme arginase I and the 
mannose receptor CD206. M2 and M2-like macrophages are 
heterogeneous and exert a broad range of immunoregulatory and 
cytoprotective functions that promote wound healing, production 
of antiinflammatory effector molecules, and local suppression of 
innate and adaptive immunity (1, 2).
Macrophages have also been subdivided into an Ly6C– tis-
sue-resident population, which patrols peripheral tissues, and 
an Ly6C+ tissue-infiltrating population, which is recruited to in-
flammatory sites. In contrast to tissue-infiltrating macrophages 
that arise from Ly6C+ monocytes, tissue-resident macrophages 
arise from Ly6C– precursors that seed peripheral tissues during 
early development and maintain their presence by homeostatic 
proliferation, as they are not replenished by circulating precur-
sors (3). This homeostatic maintenance requires the transcription 
factor TRIB1 (4) and can rely on local production of IL-34 (5). A 
subset of tissue-resident macrophages expresses CD169 (6), a re-
ceptor for sialic acid also referred to as sialoadhesin and siglec-I. 
CD11b+F4/80+Ly6C– tissue-resident macrophages reside in un-
perturbed tissues and, similar to certain CD11b+F4/80+Ly6C+ 
tissue-infiltrating macrophage subsets, can exert immunoregula-
tory or immunostimulatory functions (7–9).
In addition to their presence in peripheral tissues, CD169+ 
macrophages are found in the marginal zone of secondary lym-
phoid organs, where they can promote immune tolerance to 
soluble antigens and antigens expressed by dead cells (10, 11). 
Paradoxically, CD169+ tissue-resident macrophages, or subsets 
thereof, can also promote pathogenic central nervous system auto-
immunity (12–14) and antitumor immunity (15). Although CD169+ 
macrophages are present in many tissues, including skin (6), heart 
(16), and pancreas (17) in mice and lung, colon, and liver in hu-
mans (18), their role in shaping adaptive alloimmune responses 
and the potential for subpopulations remains enigmatic.
Here, we found that TIM-4 was highly expressed on a promi-
nent subset of Ly6C–CD169+ tissue-resident macrophages with an 
immunoregulatory phenotype and function. As CD169+ tissue-
resident macrophages constitute a major component of tissue-
resident APCs (6), we tested several hypotheses, including: (a) 
that a numerically prominent TIM-4hiCD169+ subset of Ly6C– 
tissue-resident macrophages migrates to secondary lymphoid or-
gans upon stimulation, (b) that Ly6C–TIM-4hiCD169+ macrophage 
survival is regulated by the expression of TIM-4, and (c) that the 
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of TIM-3+ Th1 cells; ref. 19) and of the ectoenzyme dephosphory-
lases CD39 and CD73 than did CD11b+F4/80+Ly6C–CD169– cells 
(Figure 1B). Collectively, CD39 and CD73 cleave proinflammatory 
ATP and generate adenosine, a molecule with potent immunoin-
hibitory and immunoregulatory properties (20, 21). Notably, many 
CD45+CD11b+F4/80+Ly6C–CD169+ tissue-resident macrophages, 
but not all, expressed high levels of TIM-4 (~40%–50%; Figure 1B), 
a receptor for phosphatidylserine (22, 23) and TIM-1 (24). In con-
trast, all CD45+CD11b+F4/80+Ly6C–CD169– skin-derived tissue-
resident macrophages were TIM-4– (Figure 1B).
Thus, skin CD11b+F4/80+ cells were quite heterogeneous, con-
sisting of at least 3 tissue-resident Ly6C– subpopulations: TIM-4– 
CD169–, TIM-4–/loCD169+, and TIM-4hiCD169+. Strikingly, we 
allograft donor TIM-4hiCD169+ macrophage subset promotes im-
munoregulation, thereby prolonging cardiac allograft survival.
Results
The TIM-4hiCD169+ phenotype defines a subset of tissue-resident mac-
rophages that migrates to secondary lymphoid organs. CD45+CD11b+ 
F4/80+Ly6C– tissue-resident macrophages isolated from the skin 
of unmanipulated C57BL/6 mice included distinct CD169– and 
CD169+ subsets (Figure 1A). Thus, we further analyzed the phe-
notype of CD11b+F4/80+Ly6C–CD169– and CD11b+F4/80+Ly6C–
CD169+ subpopulations. Interestingly, CD11b+F4/80+Ly6C–
CD169+ tissue-resident macrophages expressed higher levels of 
galectin-9 (a molecule that binds to TIM-3 and triggers deletion 
Figure 1. A subpopulation of skin-resident 
CD11b+F4/80+CD169+ tissue-resident macrophages 
with an immunoregulatory phenotype coexpresses 
TIM-4. Intradermal leukocytes were obtained from 
the skin of untreated C57BL/6 mice following col-
lagenase digestion. Cells were stained with DAPI, 
anti-CD45, anti-F4/80, anti-CD11b, anti-CD169, and 
anti-Ly6C. (A) Using a sequential gating strategy, we 
gated on live (DAPI–) CD45+ cells (not shown) and then 
identified F4/80+CD11b+ cells that were then subdi-
vided into Ly6C– subpopulations that were CD169+ and 
CD169–. (B) DAPI– CD11b+F4/80+Ly6C–CD169+ and DAPI– 
CD11b+F4/80+Ly6C–CD169– subsets of intradermal 
leukocytes were selected and assessed for the expres-
sion of TIM-4, CD39, CD73, and galectin-9 using the 
gating scheme shown in A. Shaded histograms repre-
sent fluorescence minus one (FMO) controls or anti–
TIM-4–stained Tim4–/– skin macrophages. MFIs are 
noted parenthetically. (C) The CD169–, TIM-4–/loCD169+, 
and TIM-4hiCD169+ subsets of the CD11b+F4/80+Ly6C– 
population from A and B were cell sorted and 
analyzed by real-time PCR using the listed Taqman 
probes and primers. As expected, Tim4 mRNA was 
expressed at high levels only in the TIM-4hiCD169+ 
subpopulation (P < 0.01 among the 3 groups, 1-way 
repeated-measures ANOVA). Tgfb mRNA significantly 
differed between the TIM-4hiCD169+ subpopula-
tion and both TIM-4–/lo subsets. **P < 0.01, 1-way 
repeated-measures ANOVA (P < 0.01) with Bonferroni 
post-test. Graphs represent mean ± SD from 7 unique 
animals from 3 independent experiments.
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cells were TIM-4hi (Figure 2B). This also contrasted with the hetero-
geneity of CD11b+Ly6C–CD169+ tissue-resident macrophages ex-
tracted from tissue, which contained discrete TIM-4hi and TIM-4–/lo 
subsets. Importantly, FITC+CD11b+Ly6C–TIM-4hiCD169+ mac-
rophages in the dLN possessed an F4/80hiCD169hi phenotype 
that was not present in LNs of untreated mice (Supplemental 
Figure 1A; supplemental material available online with this ar-
ticle; doi:10.1172/JCI73527DS1). Moreover, FITC–CD11b+Ly6C–
TIM-4hiCD169+ cells from FITC-painted mice were F4/80lo/int 
CD169lo/int, a phenotype similar to the resident CD11b+Ly6C– 
TIM-4hiCD169+ dLN cells found in unpainted mice (Supplemen-
tal Figure 1A). These results strongly indicate that TIM-4hiCD169+ 
tissue-resident macrophages migrated to the LN after inflamma-
tion-incited oxidative stress, rather than passively acquiring FITC. 
Only rare Ly6C+CD169+ cells were found in the skin of untreated 
mice (Figure 1A) and were therefore not further characterized.
FITC+CD11b+Ly6C–TIM-4intCD169– dLN cells (referred to here-
after as CD169– APCs) were DC-like, expressing high CD11c but 
found that the Ly6C–TIM-4hiCD169+ double-positive subpopu-
lation from unperturbed skin expressed ~60% higher transcript 
levels of Tgfb than the Ly6C–TIM-4–CD169– and Ly6C–TIM-4–/lo 
CD169+ subpopulations (Figure 1C).
We hypothesized that TIM-4hiCD169+ tissue-resident mac-
rophages would migrate to secondary lymphoid organs follow-
ing oxidative stress and exhibit an immunoregulatory phenotype 
at this critical site for T cell activation. To study tissue-resident 
rather than circulating macrophages, we used the FITC painting 
model, wherein fluorescently tagged intradermal APCs undergo 
oxidative stress following exposure to dibutyl phthalate (25, 26). 
Stimulation of intradermal APCs causes them to migrate to drain-
ing LNs (dLNs), where they are identified by the presence of FITC.
After 18 hours, we analyzed live (DAPI–) tissue-derived (FITC+) 
CD11b+ dLN cells by flow cytometry and found that, similar to 
cells derived from skin, this FITC+ dLN homing population bore 
distinct Ly6C–CD169+ and Ly6C–CD169– fractions (Figure 2A). 
In contrast to Ly6C–TIM-4intCD169– dLN cells, Ly6C–CD169+ dLN 
Figure 2. Oxidation-stressed TIM-4hiCD169+ tissue-
resident macrophages manifest a hypostimulatory 
phenotype relative to CD169– APCs after migration 
to the dLN. (A) The abdominal and thoracic skin 
of shaven C57BL/6 WT mice was painted with 1% 
FITC in 1:1 dibutyl phthalate/acetone. 18 hours later, 
dLN cells were collected and stained with DAPI, 
anti-CD11b, anti-Ly6C, and anti-CD169. We identi-
fied tissue-emigrating (FITC+) viable (DAPI–) CD11b+ 
dLN cells, which harbored distinct Ly6C–CD169+ 
and Ly6C–CD169– fractions that were subsequently 
analyzed for additional phenotypic characteristics. 
(B) We assessed DAPI–FITC+CD11b+Ly6C–CD169– and 
DAPI–FITC+CD11b+CD169+ dLN cells for expres-
sion of the indicated markers, which revealed a 
CD11cloF4/80hiSSClo macrophage-like phenotype 
for Ly6C–CD169+ dLN cells and a CD11chiF4/80loSSChi 
DC-like phenotype for Ly6C–CD169– dLN cells. Ly6C–
CD169+ macrophages expressed higher levels of  
TIM-4, but lower levels of CD86 and MHCII, com-
pared with CD169– APCs. Shaded histograms repre-
sent indicated controls. Plots are representative of 3 
independent experiments. MFIs are indicated paren-
thetically. (C) CD169+ macrophages (FITC+CD11b+Ly6C–
CD169+) and CD169– APCs (FITC+CD11b+Ly6C–CD169–) 
were isolated from the dLN of FITC-painted mice by 
FACS sorting using the gates in A and analyzed by 
real-time PCR. The ΔCtCD169+/ΔCtCD169– ratio  
(mean ± SD) is plotted for each transcript from 3 
independent experiments on a log2 scale. Dashed 
lines are plotted at ± 2-fold differences.
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subsets of skin-derived CD11b+F4/80+Ly6C– cells migrated to 
the dLN, we interrogated the phenotype of these 2 dLN-homing 
populations. Compared with dLN-homing CD169– APCs, TIM-4hi 
CD169+ macrophages expressed lower levels of CD86 and MHCII 
proteins (Figure 2B). Transcriptional analysis confirmed low-
er expression of CD80, CD86, and MHCII antigen presenta-
tion molecules in TIM-4hiCD169+ macrophages compared with 
CD169– APCs in the dLN, but revealed an increase in the expres-
sion of galectin-9, TGF-β, and the ectoenzyme dephosphorylases 
CD39 and CD73 (Figure 2C). Increased expression of galectin-9 
and CD73 cell surface protein were confirmed by flow cytometry 
low F4/80 levels and exhibiting high side scatter (SSC). Conversely, 
FITC+CD11b+Ly6C–TIM-4hiCD169+ dLN cells (referred to hereafter 
as TIM-4hiCD169+ macrophages) expressed low levels of CD11c and 
high levels of F4/80 and CD11b, and exhibited low SSC (Figure 2B).
TIM-4hiCD169+ macrophages that migrated to the dLN ex-
pressed siglec-H (Supplemental Figure 1B). However, the relation-
ship of these cells to M2-like tissue-resident macrophages bearing 
siglec family members other than CD169, found in macrophages 
isolated from adipose (4) and lung (9) tissue, remains unclear.
TIM-4hiCD169+ macrophages possess an antiinflammatory, 
immunoregulatory phenotype. As both the CD169+ and CD169– 
Figure 3. Compared with oxidation-stressed CD169– APCs, oxidation-stressed TIM-4hiCD169+ macrophages induce higher levels of FoxP3 transcripts, but 
inferior T cell survival. Live (DAPI–) CellTrace Violet–labeled ABM TCR transgenic T cells (DAPI–CD4+FoxP3/GFP–) were cocultured for 4 days with DAPI–
FITC+CD11b+Ly6C–CD169– APCs or DAPI–FITC+CD11b+Ly6C–CD169+ macrophages from the dLNs of WT FITC painted bm12 mice. (A) Proliferation in gated live 
CD4+ ABM TCR transgenic (Vα2+Vβ8+) T cells after 4 days of culture, shown in a histogram from a representative experiment. Expansion indices are indicated 
parenthetically as well as graphically. (B) The ratio of the indicated transcripts in CD169+ relative to CD169– stimulated CD4+Vα2+Vβ8+ TCR transgenic T cells 
sorted on day 4, shown as mean ± SD from 2 independent experiments on a log2 scale. (C) Frequency (mean ± SD) of CD25hiFoxP3/GFP+ cells within the gated 
CD4+Vα2+Vβ8+ population in MLRs treated without or with TGF-β (5 ng/ml), from 4–7 independent experiments. (D) Ratio of the indicated cytokines in 
CD169+ relative to CD169– stimulated MLR cultures, shown as mean ± SD from 2 independent experiments on a log2 scale. Dashed lines are plotted at ±2-fold 
differences. (E) Percent viability (mean ± SD) of CD4+Vα2+Vβ8+ T cells from MLR cultures. *P < 0.05, 1-way ANOVA (P < 0.05) with Bonferroni post-test.
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this hypothesis, we used the ABM TCR transgenic model system 
of alloreactivity (27). ABM TCR transgenic mice express a CD4+ 
TCR transgene that recognizes the mutant MHC class II (MHCII) 
molecule I-Abm12 expressed by bm12 mice. Using ABM T cells that 
express GFP driven by the Treg promoter FoxP3 (FoxP3/GFP), 
we isolated CD4+FoxP3/GFP– responder T cells and labeled them 
with CellTrace Violet. We then cultured these T cells for 4 days 
with DAPI– TIM-4hiCD169+ macrophages or with DAPI– CD169– 
APCs (which are TIM-4int) isolated from the dLN of FITC-painted 
bm12 mice. Similar to C57BL/6 strains, DAPI–FITC+CD11b+Ly6C–
CD169+ cells from the dLN of FITC-painted bm12 mice expressed 
more TIM-4, CD73, and galectin-9, but less CD86, than did DAPI–
FITC+CD11b+Ly6C–CD169– dLN cells (Supplemental Figure 2A). 
Interestingly, TIM-4hiCD169+ macrophages induced less T cell 
proliferation than did CD169– APCs (Figure 3A). A similar obser-
vation was noted when proliferation was assessed exclusively in 
transgenic T cells that express an early activation antigen (data not 
shown), which indicates that proliferation was also lower among 
transgenic T cells that had encountered antigen.
Strikingly, transcriptional analysis of transgenic MLR responder 
T cells from the aforementioned MLRs revealed that, compared 
with CD169– APCs, TIM-4hiCD169+ macrophages derived from the 
dLN of FITC painted mice induced amplified gene expression of the 
(Supplemental Figure 1B). TIM-4hiCD169+ macrophages also ex-
pressed higher levels of the tissue-resident macrophage selective 
transcription factor TRIB1 (4) than did CD169– APCs (Figure 2C). 
Thus, cell surface expression of TIM-4, galectin-9, CD73, F4/80, 
and CD169, in addition to transcript expression of the transcrip-
tion factor TRIB1 (4), identified a subset of tissue-resident mac-
rophage that migrates to the dLN in response to oxidative stress. 
TIM-4hiCD169+ macrophages maintained a hypostimulatory and 
antiinflammatory phenotype compared with CD169– APCs after 
migration to secondary lymphoid organs. We speculate that it is 
the cumulative expression of multiple immunoregulatory mol-
ecules, and the hypoexpression of MHC and costimulatory pro-
teins, rather than one individual immunoregulatory molecule, 
that gives these cells immunoregulatory potency. The precise con-
tribution of each individual immunoregulatory molecule is diffi-
cult to assess in a system that is likely to be overdetermined.
TIM-4hiCD169+ macrophages promote greater Treg differentiation 
and proliferation in the mixed lymphocyte reaction than do CD169– 
APCs. Based on their hypostimulatory and antiinflammatory 
phenotype, we hypothesized that, compared with viable CD169– 
APCs, viable TIM-4hiCD169+ macrophages from the dLN would 
favor generation of Treg over effector T cell (Teff) responses when 
used as mixed lymphocyte reaction (MLR) stimulators. To test 
Figure 4. The presence of tissue-resident FITC+CD11b+Ly6C–CD169+ macrophages is increased in dLNs of Tim4–/– compared with WT mice after oxidative 
stress. (A) Higher frequency of DAPI–FITC+CD11b+Ly6C– cells expressing CD169 in Tim4–/– versus WT dLNs 18 hours after FITC painting (P < 0.0001).  
(B) Higher percent viability of gated FITC+CD11b+Ly6C–CD169+ macrophages in Tim4–/– versus WT dLNs (P < 0.05), as determined by gate-exclusion of dead 
and dying cells (see Supplemental Figure 3A). (C) Higher absolute number of DAPI–FITC+CD11b+Ly6C–CD169+ (P < 0.01), but not CD169– (P = NS), dLN cells in 
Tim4–/– versus WT FITC-painted mice. (D) Tim4–/– DAPI–FITC+CD11b+Ly6C–CD169+ macrophages bound less annexin V than WT DAPI–FITC+CD11b+Ly6C–CD169+ 
macrophages (P < 0.01). (E) CD4+FoxP3/GFP– T cells from ABM TCR transgenic mice were sorted, labeled, and cocultured with CD169– APCs or CD169+ mac-
rophages from dLNs of FITC-painted Tim4–/– bm12 mice (as described in Figure 3A for WT bm12). Proliferation was reduced in ABM TCR transgenic T cells 
cultured with Tim4–/– CD169+ versus CD169– MLR stimulator cells. Plots are representative of 3 independent experiments. Expansion indices are indicated 
parenthetically. (F) Ratio of the indicated transcripts in Tim4–/– CD169+ versus CD169– stimulated CD4+Vα2+Vβ8+ TCR transgenic T cells sorted on day 4 
(mean ± SD from 2 independent experiments on a log2 scale).
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immunoregulatory transcription factor FoxP3 relative to the Teff 
transcription factors Tbet and GATA3 in MLR responder T cells (Fig-
ure 3B). We also found an average 2.5-fold increase in FoxP3/GFP 
expression in T cells stimulated with CD169+ versus CD169– MLR 
stimulator cells, as determined by GFP reporter expression (Figure 
3C and Supplemental Figure 2B). This finding was consistent with the 
prior observation that lung-derived macrophages from uninflamed 
lungs promote FoxP3 expression (9). When used in a T-suppressor 
assay, unlabeled TCR transgenic CD4+FoxP3/GFP+ Tregs isolated 
from CD169+ macrophage–stimulated MLR cultures suppressed the 
proliferation of TCR transgenic CD4+FoxP3/GFP– responder T cells 
in response to T cell–depleted (CD90–) bm12 splenocytes (Supple-
mental Figure 2C), demonstrating the regulatory activity of these 
cells. Thus, tissue-resident macrophages maintain immunoregula-
tory potential after stimulation and migration to the dLN.
TIM-4hiCD169+ macrophages engender poor overall T cell sur-
vival in the MLR relative to CD169– APCs. Consistent with our MLR 
proliferation data, we observed lower levels of TNF-α, IL-6, IL-10, 
IL-4, and IL-5 in the undiluted supernatants of TIM-4hiCD169+ 
macrophage–stimulated versus CD169– APC–stimulated MLR 
cultures (Figure 3D). There was, however, an increase in IFN-γ 
in TIM-4hiCD169+ macrophage–stimulated versus CD169– APC-
stimulated MLR cultures (Figure 3D).
As IFN-γ (28–30) and galectin-9 (19) promote Th1 cell apop-
tosis and transplant tolerance, we measured the viability of TCR 
transgenic T cells in these MLR cultures. TIM-4hiCD169+ stimula-
tor macrophages engendered poor T cell survival relative to CD169– 
stimulator APCs (Figure 3E). We cannot exclude the possibility that 
such alterations in viability may contribute to the observed reduc-
tion in effector cytokine production, or that decreased prolifera-
tion may affect the percent viability. Blockade with anti–galectin-9 
caused a modest but statistically insignificant survival increase in 
TIM-4hiCD169+ macrophage-stimulated T cells, despite high rela-
tive expression of galectin-9 in this population. Thus, the contribu-
tion of galectin-9 to the observed T cell death is likely but one com-
ponent of an overdetermined system in which multiple effector 
molecules have overlapping functions, thereby making it difficult 
to ascertain the absolute contribution of a specific molecule (30).
Figure 5. CD169+ peritoneal macrophages are resistant to H2O2-induced apoptosis in Tim4–/– relative to WT mice. (A) Histograms of gated WT or 
Tim4–/– DAPI–CD11b+F4/80+ peritoneal macrophages revealed TIM-4 and CD169 expression, but not Ly6C expression. Shaded histograms represent 
indicated controls. MFI is noted parenthetically. (B–D) Gated WT or Tim4–/– CD11b+F4/80+ peritoneal macrophages incubated in the presence or absence 
of H2O2 (125 μM unless otherwise indicated) were analyzed for DAPI and annexin V binding by flow cytometry. (B) Representative flow cytometry plots 
at 3 hours after treatment. (C) Summary graphs from 1 of 3 independent experiments, showing lower apoptosis (DAPI–annexin V+) and cell death 
(DAPI+annexin V+) in Tim4–/– versus WT CD11b+F4/80+ macrophages. *P < 0.05, **P < 0.01, ***P < 0.001, ANOVA (P < 0.0001) with Bonferroni post-test. 
(D) Dose-response curve showing less apoptosis (DAPI–annexin V+) in Tim4–/– versus WT CD11b+F4/80+ macrophages at 3 hours. ***P < 0.001, ANOVA 
(P < 0.01) with Bonferroni post-test. (E and F) Gated CD11b+F4/80+ macrophages treated with 125 μM H2O2 for 3 hours were permeabilized and stained 
for intracellular active caspase-3 in triplicate. Shown are representative histograms (E) and summary graphs showing active caspase-3 MFI and fre-
quency of active caspase-3+ macrophages from 1 of 2 independent experiments (F). Active caspase-3 levels in gated Tim4–/– macrophages was reduced 
compared with WT macrophages. P values were determined by ANOVA (P < 0.01) with Bonferroni post-test. All graphs depict mean ± SEM from a 
representative experiment performed in triplicate.
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Next, we cultured ABM TCR transgenic T cells with a 1:1 mix-
ture of CD169– APCs and TIM-4hiCD169+ macrophages. As viabil-
ity was similar between the 1:1 mixture and pure CD169– cultures 
(Figure 3E), the decrease in viability linked to TIM-4hiCD169+ 
macrophages therefore arose from a mechanism that was counter-
acted or diluted by the presence of CD169– APCs. Together, these 
data demonstrated that, compared with CD169– APCs, the control 
of Teff responses by TIM-4hiCD169+ macrophages is multifaceted 
and includes (a) greater induction of Tregs relative to other T cell 
subsets, (b) reduction of overall T cell proliferation, and (c) a high-
er rate of death among activated T cells.
Addition of TGF-β to these MLR cultures increased the fre-
quency of CD4+ T cells expressing FoxP3 in cultures stimulated 
with TIM-4hiCD169+ macrophages compared with CD169– APCs 
(Figure 3C and Supplemental Figure 2B). Thus, even the addition 
of high levels of exogenous TGF-β did not put CD169– APCs on par 
with TIM-4hiCD169+ macrophages in their ability to induce Tregs. 
Hence, the immunoregulatory activity of these cells likely extends 
beyond TGF-β expression. T cells cultured in the presence of 
TGF-β and either TIM-4hiCD169+ macrophages or CD169– APCs 
exhibited viability similar to that of T cells cultured with the same 
APC population in the absence of TGF-β (Figure 3E).
TIM-4hiCD169+ macrophages are highly susceptible to TIM-4– 
dependent apoptosis. Next, we FITC-painted the skin of WT 
and Tim4–/– mice and analyzed CD169 expression on DAPI–
FITC+CD11b+Ly6C– cells that migrated to the dLN. Strikingly, 
Tim4–/– mice possessed a greater frequency of viable CD169+ 
macrophages in dLNs compared with WT mice (Figure 4A). Thus, 
while CD169+ macrophages expressed high levels of TIM-4 in WT 
mice, there was an increase in CD169+ cellularity in Tim4–/– mice, 
despite the absence of TIM-4 expression.
We hypothesized that the increase in CD169+ macrophage 
frequency observed in the dLN of FITC-painted Tim4–/– mice 
was due to a decrease in TIM-4–dependent apoptotic death of 
CD169+ macrophages. In support of this hypothesis, CD169+ 
macrophage viability was found to be significantly higher in 
Tim4–/– mice than WT mice, as determined by analyses that ex-
cluded cells undergoing shrinkage (low forward scatter) or failed 
to exclude viability dyes (Figure 4B and Supplemental Figure 
3A). We also observed an increase in the absolute number of vi-
able CD169+ macrophages in dLNs of Tim4–/– mice (Figure 4C). 
In contrast, there was no significant difference in the absolute 
number of viable CD169– APCs obtained from the dLNs of WT 
and Tim4–/– FITC-painted hosts (Figure 4C), despite low to inter-
mediate expression of TIM-4 by these cells.
WT CD169+ macrophages from the dLN of FITC-painted 
mice bound annexin V, a marker for cells undergoing programmed 
cell death, more intensely than did Tim4–/– CD169+ macrophages 
(Figure 4D), which suggests that, among cells that migrate to the 
dLN, WT TIM-4hiCD169+ tissue-resident macrophages are more 
susceptible to apoptosis than are Tim4–/– CD169+ tissue-resident 
macrophages. In contrast, the proportion of CD169+ cells express-
ing the Ki-67 proliferation-specific antigen was similar in WT and 
Tim4–/– CD169+ macrophages (Supplemental Figure 3B). Thus, the 
Figure 6. Tim4–/– heart allografts exhibit prolonged Treg-dependent transplant survival compared with WT allografts. (A) C57BL/6 WT and C57BL/6 
Tim4–/– hearts were transplanted into fully allogeneic WT BALB/c mice, with or without Treg-depleting anti-CD25 treatment of recipients on day –1 relative 
to transplantation. The prolonged survival of allogeneic Tim4–/– versus WT heart allografts (P < 0.0001, log-rank Mantel-Cox analysis) was abrogated by 
anti-CD25 pretreatment of the recipients. (B) 7 days after transplantation, transplanted hearts were removed, formalin fixed, paraffin embedded, and 
stained with H&E. Original magnification, ×400. Images are representative of 5 fields observed from 3 independent transplanted hearts per group. (C) 
Graft-infiltrating mononuclear cells were isolated from WT or Tim4–/– heart allografts transplanted into BALB/c mice 7 days after transplantation. FoxP3 
expression was detected in live (Live/Dead Blue–) CD4+ T cells by intracellular staining. Shown are representative flow cytometry plots and summary graph. 
(D) Mice were transplanted as in A. Rapamycin treatment induced indefinite survival of Tim4–/– hearts, but merely prolonged survival of WT hearts  
(P < 0.01, log-rank Mantel-Cox analysis).
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does not possess an identified signaling domain (35). Nonetheless, 
the phenomenon is TIM-4 dependent.
Transplantation of Tim4–/– heart allografts manifests prolonged 
Treg-dependent survival compared with WT heart allografts. Using 
Tim4–/– mice as a tool, we tested the hypothesis that improved 
survival of CD169+ tissue-resident macrophages migrating out of 
donor heart allografts, perhaps in response to IRI, would promote 
immunoregulation and allograft survival in the cardiac allograft 
transplantation model. In this model, we can selectively test the 
influence of donor tissue-resident macrophage cell survival on 
adaptive immunity, since it is possible to ablate TIM-4 in donor 
alloantigen-presenting tissue-resident macrophages without the 
confounding influences of TIM-4 deletion upon recipient cir-
culating leukocytes. To this end, we transplanted WT or Tim4–/– 
C57BL/6 hearts into WT allogeneic BALB/c recipients. Similar to 
tissue-resident macrophages in skin, the vast majority of CD169+ 
macrophages in WT transplanted hearts expressed high levels of 
TIM-4 (Supplemental Figure 5). Given that CD169, but not TIM-4, 
was present on tissue-resident macrophages in Tim4–/– donor 
hearts 3 days after transplantation, and that TIM-4 was present on 
CD169+ tissue-resident macrophages in naive untransplanted WT 
hearts (Supplemental Figure 5), we concluded that the intragraft 
TIM-4hiCD169+ macrophages observed 3 days after transplanta-
tion were donor-derived rather than graft-infiltrating and did not 
require TIM-4 to develop.
Strikingly, Tim4–/– heart allografts survived longer than those of 
WT controls (median survival, 45 vs. 9 days; P < 0.0001; Figure 6A). 
Moreover, Tim4–/– bm12 skin allograft survival was prolonged com-
pared with WT bm12 skin in ABM TCR transgenic recipients (Sup-
plemental Figure 6A). While prolongation was not as dramatic in 
skin compared with heart transplants, this was expected, because 
skin allografts are widely known to be less amenable to tolerance 
induction or prolonged engraftment than other conventionally 
transplanted tissues (36). Assessment of the absolute number and 
viability of donor CD169+ tissue-resident macrophages in trans-
planted tissues proved technically challenging, since few viable 
CD169+ tissue-resident macrophages, in contrast to infiltrating 
recipient macrophages, could be recovered after collagenase di-
gestion (data not shown).
The prolonged survival of Tim4–/– heart allografts was com-
pletely dependent on the presence of CD25+ Tregs (Figure 6A). In 
parallel with prolonged allograft survival, fewer mononuclear and 
total CD3+ T lymphocytes, but more Tregs, infiltrated Tim4–/– ver-
sus WT transplants 7 days after transplantation (Figure 6, B and C, 
and data not shown). Moreover, survival of Tim4–/–, but not WT, 
heart allografts was prolonged indefinitely (>120 days) by the addi-
tion of a short, 2-week course of rapamycin treatment in transplant 
recipients (Figure 6D). Rapamycin treatment is known to enhance 
the differentiation of CD4+ T cells to Tregs and facilitate the induc-
tion of transplant tolerance (37). In contrast to Tim4–/– donor hearts 
transplanted into WT recipients, WT hearts were rapidly rejected 
in both WT and Tim4–/– recipients (Supplemental Figure 6B).
Discussion
Recently, tissue-derived M2-like macrophages were noted to play 
important roles in regulating local innate (4) and adaptive (9) im-
mune responses; however, the relationship between these M2-
greater number of CD169+ macrophages in Tim4–/– versus WT mice 
was attributable to an increase in survival rather than proliferation.
It seems paradoxical that immunoregulatory CD169+ mac-
rophages express high levels of TIM-4, a potent costimulator of 
TIM-1+ T cells (24, 31, 32). We therefore hypothesized that TIM-4 
expression decreases the survival, but does not compromise the 
immunoregulatory potential, of this population. To test this hy-
pothesis, we isolated CD169+ macrophages and CD169– APCs 
from the dLNs of FITC-painted Tim4–/– bm12 mice and cultured 
them in the MLR with ABM TCR transgenic T cells, a short-term 
system in which APC survival is unlikely to play a significant role. 
Like WT TIM-4hiCD169+ macrophage stimulator cells, Tim4–/– 
CD169+ macrophage stimulator cells supported less T cell pro-
liferation compared with Tim4–/– CD169– APCs (Figure 4E and 
Supplemental Figure 2D). Interestingly, 1-way ANOVA showed 
no significant difference in proliferation between WT and Tim4–/– 
CD169+ macrophages or between WT and Tim4–/– CD169– APCs. 
Compared with Tim4–/– CD169– APCs, Tim4–/– CD169+ macro-
phage stimulator cells also induced enhanced FoxP3 transcript 
expression, as well as FoxP3/GFP transgene reporter expression, 
by responder T cells, compared with Tbet and GATA3 transcript 
expression (Figure 4F and Supplemental Figure 2, B and E). Thus, 
the expression of TIM-4 on CD169+ macrophages negatively in-
fluenced their survival, but did not grossly dilute their immuno-
regulatory potential.
Tim4–/– CD169+ peritoneal macrophages are resistant to H2O2-
induced cell death relative to WT CD169+ peritoneal macrophages. 
We sought to compare apoptotic susceptibility of WT and Tim4–/– 
tissue-resident macrophages in a controlled in vitro assay system. 
As isolation of TIM-4+ tissue-resident macrophages from skin 
yields very few viable cells, the procedure for digesting tissues us-
ing collagenase proving particularly detrimental to tissue-resident 
cell viability (data not shown), we chose to assay peritoneal macro-
phages that express TIM-4. Like Ly6C–CD169+ skin-dwelling mac-
rophages, all F4/80+CD11b+ peritoneal macrophages were Ly6C– 
and CD169+, as well as CD39+ and CD73+, and most expressed 
TIM-4 (~85%–90%; Figure 5A and Supplemental Figure 4A), which 
demonstrated that peritoneal resident macrophages share at least 
7 phenotypic markers in common with skin tissue-resident mac-
rophages. To determine whether TIM-4 ablation reduces perito-
neal macrophage apoptosis induced by oxidative stress ex vivo, we 
treated WT and Tim4–/– peritoneal exudate cells with the oxidative 
stressor H2O2. H2O2 is one of several reactive oxygen species that 
is generated as a part of most oxidation stress responses, including 
the responses to phthalates used in FITC painting (33) and isch-
emia-reperfusion injury (IRI) associated with transplantation (34). 
Strikingly, treatment with 125 μM H2O2 rendered Tim4–/– CD169+ 
peritoneal macrophages resistant to H2O2-induced programmed 
cell death compared with WT peritoneal macrophages (Figure 5B). 
This resistance was conferred in a time- and dose-dependent 
manner (Figure 5, C and D, and Supplemental Figure 4B). Addi-
tionally, a decrease in caspase-3 activation in Tim4–/– versus WT 
macrophages was also noted in the presence of H2O2, but not in its 
absence (Figure 5, E and F). We therefore concluded that TIM-4 
expression renders CD169+ macrophages highly susceptible to 
apoptosis induced by oxidative stress, although it remains unclear 
whether TIM-4 plays a direct or indirect role in this process, as it 
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plant tolerance in vivo and in vitro (41, 42). Moreover, TIM-4hi 
CD169+ macrophage stimulator cells severely compromised over-
all Teff survival (in contrast to the robust Teff survival generated 
by CD169– APCs), which changed the balance of Tregs and Teffs 
in favor of Tregs.
Despite high levels of TIM-4 expression on CD169+ macro-
phages in WT FITC-painted mice, the abundance of CD169+ cells 
was increased in Tim4–/– mice, despite their lack of TIM-4 expres-
sion. Moreover, genetic ablation of TIM-4 expression in CD169+ 
peritoneal macrophages, ~85%–90% of which expressed TIM-4 
in WT mice, rendered them resistant to oxidative stress–induced 
apoptosis. As TIM-4 lacks an intrinsic signaling domain (35, 43), 
it is likely that the role of TIM-4 is to bring dying cells that expose 
phosphatidylserine on their cell surface into close proximity with 
additional signal-inducing receptors.
TIM-4 expression was not assessed in previous studies de-
tailing the important role of CD169+ marginal zone macrophages 
in mediating tolerance to soluble and dead cell antigens (10, 11). 
Our data indicate that TIM-4 is necessary, but not necessarily suf-
ficient, for the induction of apoptosis, and thus leads to apoptosis 
only when additional stimulation conferred by oxidative stress 
is encountered. In this way, immunoregulatory macrophages can 
be selectively eliminated when a potent immune response arises 
under inflammatory conditions. As TIM-4 lacks a signaling do-
main (35), it seems probable that TIM-4 plays an indirect role in 
macrophage apoptosis.
The immunoregulatory molecular phenotype of TIM-4hi 
CD169+ macrophages led us to speculate that, like activated TIM-3+ 
Tregs (44), the survival of TIM-4hiCD169+ macrophages and their 
immunoregulatory potential is compromised in inflammatory 
settings. Strikingly, TIM-4hiCD169+ macrophages that migrate 
to dLNs are highly susceptible to apoptosis induced by oxidative 
stress, a feature of obvious importance to the long-term regulatory 
potential of these M2-like macrophages. The fragility of TIM-4hi 
CD169+ macrophages fits the model proposed for other cellu-
lar protagonists of immunoregulation: the immune system must 
eventually disarm immunoregulatory cells such that protective 
antimicrobial Teff responses in the given microenvironment are 
not unduly restrained. This fragility, however, becomes an obsta-
cle under intense inflammatory conditions in which immunoregu-
lation is desired. For example, transplanted allografts inevitably 
undergo oxidative stress as a consequence of IRI (45).
In IRI, a process inextricably associated with organ or tissue 
transplantation, it might be desirable to bolster survival of regu-
latory TIM-4hiCD169+ tissue-resident M2 macrophages. We ob-
served a significant prolongation of heart allograft survival as a 
consequence of genetic TIM-4 ablation in donor cardiac and skin al-
lografts. Moreover, a short course of suboptimal rapamycin therapy 
generated long-term CD25+ T cell–dependent survival of Tim4–/–, 
but not WT, allografts. Rapamycin is known to support Treg re-
sponses while suppressing Teff responses (46). As TIM-4 expres-
sion on WT CD169+ macrophages did not compromise the immu-
noregulatory nature of CD169+ tissue-resident macrophages in in 
vitro MLR assays, it seems more likely that genetic TIM-4 ablation 
promotes allograft survival by enhancing CD169+ macrophage sur-
vival, rather than by blocking costimulation (21, 32, 33) of TIM-1+ T 
cells by TIM-4hi immunoregulatory macrophages. While we could 
like tissue-resident macrophages, typically Ly6C– cells, and the 
Ly6C–CD169+ tissue-resident macrophage subsets was not ana-
lyzed. The data reported herein led us to conclude that a TIM-4hi 
Ly6C–CD169+ tissue-resident macrophage population: (a) con-
stitutes a major subset of Ly6C– tissue-resident macrophages, (b) 
homes to dLNs, a major site for T cell activation, upon oxidative 
stress, (c) exhibits an immunoregulatory and hypostimulatory 
phenotype that is maintained after migration to dLNs, (d) favors 
preferential induction of antigen-stimulated Tregs, (e) is highly 
susceptible to apoptosis, and (f) is rendered resistant to apopto-
sis via genetic ablation of TIM-4 expression. As a consequence, 
Tim4–/– heart allografts placed into untreated recipients survived 
much longer than WT hearts and survived indefinitely with the 
addition of a short, suboptimal rapamycin treatment regimen. 
Inflammation creates a milieu in which there is oxidative stress. 
Thus, TIM-4hiCD169+ tissue-resident macrophages are immuno-
regulatory and hypostimulatory, but their long-term influence is 
diminished by their susceptibility to programmed cell death in 
response to oxidative stress.
Our data provided strong evidence that oxidation-stressed 
TIM-4hiCD169+ tissue-resident macrophages home to secondary 
lymphoid organs in sizeable numbers, where they likely influence 
adaptive immunity. Relative to CD169– APCs, TIM-4hiCD169+ 
macrophages exhibited a phenotype that was immunoregulatory, 
both in unperturbed tissue and after migration to the dLN, where 
they seem certain to encounter antigen-specific T cells. In contrast 
to CD169– APCs, TIM-4hiCD169+ macrophages expressed low lev-
els of antigen presentation (MHCII) and costimulatory (CD80 and 
CD86) molecules, but higher levels of antiinflammatory (CD39, 
CD73, galectin-9, and TGF-β) molecules. Other immune cells 
with broad immunoregulatory properties, including Tregs (20), 
hematopoietic stem cells (38), and mesenchymal stem cells (39), 
express CD39 and CD73. As these cells express multiple immuno-
regulatory molecules, the principal effector molecule responsible 
immunoregulation expressed by a given CD39+CD73+ cell can 
vary from test system to test system.
Notably, TIM-4hiCD169+ macrophages expressed higher lev-
els of the tissue-resident macrophage-associated transcription 
factor TRIB1 (4) than did CD169– APCs. Thus, dual cell surface 
expression of CD169 and TIM-4 serves as a key identifier of this 
population of tissue-resident M2-like macrophages after migra-
tion to secondary lymphoid organs. Their expression of high levels 
of CD169 and F4/80 also distinguishes migratory tissue-resident 
macrophages from TIM-4hiCD169+ macrophages found in the 
dLN of untreated mice. As we are presently unable to identify a 
single unique marker for the tissue-resident macrophage lineage, 
fate-mapping studies using ROSA26 reporter mice (40) are not 
possible at this time.
Stimulation by TIM-4hiCD169+ macrophages versus CD169– 
APCs has a profound influence on CD4+ T cell proliferation, surviv-
al, and differentiation. In the MLR, compared with CD169– APCs, 
TIM-4hiCD169+ macrophage stimulator cells induced abundant 
expression of the immunoregulatory T cell transcription factor 
FoxP3, relative to the Teff transcription factors Tbet and GATA3. 
The ~2.5-fold increase in FoxP3/GFP expression in CD169+ ver-
sus CD169– APC-stimulated T cells in the MLR was similar to 
our in vivo observations, as well as several other models of trans-
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Mice. WT male C57BL/6J and BALB/cJ mice were obtained from 
Jackson Laboratories. C57BL/6 Tim4–/– mice were described previous-
ly (51). WT bm12 [B6(C)-H2-Ab1bm12/HkEgJ] mice were obtained from 
Jackson Laboratories and crossed with Tim4–/– mice to generate Tim4–/– 
bm12 mice as described below. ABM TCR transgenic mice bearing the 
FoxP3/GFP reporter were bred in our facility (27).
Phenotypic analysis of skin-derived tissue-resident macrophages. 
Shaven skin from untreated mice was cut into small 1- to 2-mm frag-
ments, then digested for 20 minutes in RPMI with 10% FBS and 1 mg/ml 
collagenase D or 0.07 mg/ml Liberase DL (Roche Applied Science). 
Fragments were passed through a metal sieve with light agitation and 
sequentially passed through 70- and 40-μm nylon filters. No ficoll 
gradient purification was performed for skin samples. Cells were then 
stained and analyzed by flow cytometry.
FITC painting. FITC painting was performed by applying 0.5 ml 
of 1% FITC (Sigma-Aldrich) in 1:1 acetone/dibutyl phthalate (Sigma-
Aldrich) to the abdomen and thorax of shaven mice as described 
previously (52). 18 hours after application, the dLNs were collected, 
prepared into single-cell suspensions, and analyzed by flow cytom-
etry as described below.
Antibodies, flow cytometry, and cell sorting. Single-cell suspensions 
were prepared, incubated with anti-CD32/CD16 (Fc Block; BD Biosci-
ences), and stained with the indicated viability dye and antibodies. 
The following monoclonal antibodies were used: anti-CD4 (GK1.5; 
BioLegend), anti–TCR Vβ8.1/8.2 (KJ6-133.18; BioLegend), anti–TCR 
Vα2 (B20.1; BioLegend), anti-CD11b (M1/70; BioLegend), anti-F4/80 
(BM8; BioLegend), anti-CD11c (N418; BioLegend), anti-CD169 
(3D6.112; BioLegend), anti–TIM-4 (5G3; BioLegend), anti-CD86 (GL-1; 
BioLegend), anti–I-Ab (AF6-120.1; BioLegend), anti–siglec-H (551; 
BioLegend), anti-CD73 (TY/11.8; BioLegend), anti–galectin-9 (RG9-35; 
BioLegend), anti–caspase-3 active form (C92-605; BD Biosciences), 
anti-FoxP3 (FJK-16s; eBioscience). Live/Dead Blue or Yellow Fixable 
Stains (Life Technologies), Fixable Viability Dye eFluor 780 (eBiosci-
ence), or DAPI (BioLegend) was used to assess viability. Intracellular 
staining for activate caspase-3 was performed after extracellular stain-
ing using BD Cytofix/Cytoperm reagents (BD Biosciences). Staining 
for intracellular FoxP3 was performed after extracellular staining and 
subsequent permeabilization with FoxP3 fixation/permeabilization 
reagents (eBioscience). Data acquisition was performed on a special-
order 5-laser LSRII flow cytometer (BD Biosciences). Cells were sort-
ed using a FACS Aria or Aria II (BD Biosciences). In all sorting experi-
ments, as well as analysis of dLN APCs, we applied 3 successive singlet 
gates to avoid including doublets (SSC-A/SSC-H, SSC-H/SSC-W, and 
FSC-H/FSC-W). Purity after sorting was routinely >97%. Analyses, 
including the embedded Expansion Index algorithm, were performed 
using FlowJo software (Tree Star).
MLR. DAPI–FITC+CD11b+Ly6C– CD169+ macrophages and 
CD169– APCs were isolated from FITC-painted WT or Tim4–/– bm12 
mice. 2.5 × 104 sorted APCs were incubated with 105 sorted ABM 
CD4+FoxP3/GFP– T cells labeled with CellTrace Violet (Life Technol-
ogies) in round-bottomed 96-well plates. For 1:1 mixed APC experi-
ments, 2.5 × 104 cells from each subset were combined. Media was 
IMDM (Thermo Fisher Scientific) supplemented with 10% heat-inac-
tivated FBS (Atlanta Biologics), 20 ng/ml IL-2 (Biolegend), penicillin/
streptomycin/l-glutamine (Lonza), and Mycozap Plus-PR (Lonza). 
Plate-bound anti-CD3–stimulated (10 μg/ml) and soluble anti-CD28–
stimulated (5 μg/ml) cultures were performed in flat-bottomed 
not demonstrate that improved survival of CD169+ tissue-resident 
macrophages as a result of genetic TIM-4 ablation was directly 
responsible for Treg generation and transplant survival, as deple-
tional studies are not possible at this time, our in vitro MLR results 
indicated that this is the most likely data-supported explanation.
The importance of CD169+ tissue-resident macrophages in 
promoting allograft survival is consistent with data showing that 
the adoptive transfer of other M2-like macrophage subsets, such 
as Kupffer cells (47) or classic M2 macrophages differentiated 
from Ly6C+ monocytes (48), prolong allograft survival. Our data 
are also consistent with the finding that the adoptive transfer of 
siglec-H+ lung-derived macrophages suppresses asthmatic lung 
inflammation (9).
It was previously proposed that therapeutic anti–TIM-4 treat-
ment inhibits CD4+ T cells that express a TIM-4 ligand and that 
anti–TIM-4 could reduce proinflammatory cytokine secretion in 
bone marrow–derived macrophages (BMDMs) (49); however, 
the authors did not assess Ly6C–CD169+ tissue-resident macro-
phages, which differ considerably from BMDMs developmentally 
and functionally. Additionally, as we submitted this paper, an anti–
TIM-4 mAb that does not discriminate between donor and recipi-
ent TIM-4 was shown to promote prolonged Treg-dependent skin 
allograft survival (41) by skewing Teff generation and promoting 
Tregs in response to CD11c+ Flt3L-induced DCs. However, the 
use of splenic CD11c+ stimulators makes it unclear whether this is 
a result of a change in DC phenotype or an alteration in the con-
stituent subsets within the CD11c+ population. It is possible that 
TIM-4 blockade may act through multiple, distinct mechanisms 
on tissue-resident macrophages, BMDMs, and DCs. It is also pos-
sible that antibody blockade and genetic blockade of TIM-4 func-
tion through different mechanisms.
Ly6C+ macrophages contain a CD169+ subset (Figure 2A), as 
does a small subset of DCs that resides outside of the marginal 
zone in secondary lymphoid organs (50). The use of a transplan-
tation model enabled us to assess the effect of tissue-derived, 
alloantigen-expressing (donor) versus blood-derived (recipient) 
macrophage populations. Our results clearly demonstrated that 
donor-derived alloantigen-expressing TIM-4hiCD169+ tissue-pa-
trolling macrophages play an important immunoregulatory role in 
the alloimmune response in vivo.
We conclude that TIM-4hiCD169+ tissue-resident macro-
phages, but not TIM-4–/loCD169+ tissue-resident APCs, migrate to 
the dLN and possess an immunoregulatory phenotype that is main-
tained upon migration to the dLN. This subset of tissue-resident 
macrophages promotes immunoregulatory adaptive immunity 
in vitro and in vivo; however, these cells are highly susceptible to 
TIM-4–dependent, stress-induced apoptosis. Genetic ablation of 
Tim4 reduced the susceptibility of CD169+ tissue-resident macro-
phages to stress-induced apoptosis. As a likely consequence of this 
ablation, we observed an increase in the prominence of intragraft 
Tregs and improved Tim4–/– heart transplant survival in vivo. Thus, 
the survival or demise of TIM-4hiCD169+ macrophages is an impor-
tant feature in determining the outcome of the allograft response 
and, almost certainly, other tissue-based immune responses.
Methods
Further information can be found in Supplemental Methods.
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until day 13 (42). Transplant viability was assessed daily by abdomi-
nal palpation. Rejection was defined as the day on which contractility 
ceased completely. Cessation of cardiac function was verified by visu-
ally inspecting the allograft.
Isolation of mononuclear leukocytes from heart transplants. Mono-
nuclear cells were isolated from transplanted cardiac grafts by collage-
nase digestion and ficoll gradient purification as described previously 
(53). Briefly, extracted hearts were cut into small 1- to 2-mm fragments, 
digested for 20 minutes in RPMI (Thermo Fisher Scientific) with 10% 
FBS (Atlanta Biologics) and 1 mg/ml collagenase D (Sigma-Aldrich), 
purified by ficoll (Sigma-Aldrich) gradient centrifugation, stained 
with anti-CD4 and Live/Dead Blue, permeabilized, stained with anti-
FoxP3, and then analyzed by flow cytometry.
Statistics. Statistical analyses were performed with Prism soft-
ware (GraphPad). 2 means were compared using nonparametric 
2-tailed Mann-Whitney t test. 3 or more means were compared using 
1- or 2-way ANOVA with Bonferroni post-test. Allograft survival curves 
were generated by the Kaplan-Meier method and compared using log-
rank Mantel-Cox statistical analysis. Allograft survival duration is pre-
sented as median survival time. In all cases, a P value less than 0.05 
was considered significant.
Study approval. All mice were certified to be specific pathogen–
free and cared for in accordance with the guidelines of the Institution-
al Animal Care and Use Committee at Beth Israel Deaconess Medical 
Center (Boston, Massachusetts, USA).
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96-well plates. After 96 hours, live ABM CD4+Vα2+Vβ8+ transgenic T 
cells were sorted and analyzed by real-time PCR (see below). Viability 
was measured using Live/Dead Blue or Yellow (Invitrogen) or eFluor 
780 fixable viability stain (eBioscience). Anti–galectin-9–treated wells 
were supplemented with 50 μg/ml purified Low Endotoxin Azide Free 
(LEAF) anti–galectin-9 (RG9-35; BioLegend).
Measurement of cytokines. Cytokines were measured in the super-
natants of MLR cultures using mouse Th1/Th2 and mouse inflamma-
tion Cytometric Bead Arrays (BD Biosciences). The concentrations 
of the experimental samples were determined by interpolating their 
value from a standard curve generated from the MFIs of the provided 
standards. The ratio of select cytokines present in supernatants of 
MLR cultures in which ABM T cells were stimulated by either alloge-
neic CD169+ or CD169– APCs was calculated (CD169+/CD169–), then 
plotted on a log2 axis.
Real-time PCR. The indicated T cells or APCs were sorted directly 
into lysis buffer RLT (Qiagen). RNA was extracted from isolated cells 
using the RNeasy Micro Kit (Qiagen). cDNA was generated using the 
TaqMan High Capacity Reverse Transcription Kit (Applied Biosystems). 
cDNA was analyzed by real-time PCR using the SYBR green method (SA 
Biosciences or Life Technologies) on a StepOne real-time PCR thermo-
cycler (Life Technologies). Data were normalized to the Gapdh house-
keeping control gene and using the ΔCt method of quantitation. Tran-
script ratios (ΔCtCD169+/ΔCtCD169) were calculated and plotted on a log2 
axis. Primer sequences are provided in Supplemental Table 1.
Measurement of peritoneal macrophage apoptosis by flow cytometry. 
Peritoneal exudate cells were collected by peritoneal lavage using 5 ml 
IMDM media (Thermo Fisher Scientific) supplemented with 10% FBS 
(Atlanta Biologics). For flow cytometric measurement, 0.1 ml contain-
ing 5 × 104 cells was seeded into 5-ml FACS tubes or 2-ml polypropyl-
ene cluster tubes and treated with the indicated concentration of H2O2 
(Sigma-Aldrich) for the indicated times. Cells were then stained with 
anti-F4/80, anti-CD11b, DAPI, and annexin V (BioLegend) in culture 
medium containing Ca2+ and Mg2+, without washing, and analyzed 
15 minutes later by flow cytometry.
Heterotopic heart transplantation. Heterotopic heart transplanta-
tion was performed as described previously (42) using male BALB/cJ 
recipients and age-matched male C57BL/6J WT or male C57BL/6 
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